Guobang Pharma Ltd. (SHA:605507)
China
· Delayed Price · Currency is CNY 20.38
+0.13 (0.64%)
Jun 6, 2025, 2:45 PM CST
Guobang Pharma Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Market Capitalization | 11,385 | 11,513 | 9,813 | 14,792 | 16,111 | - | Upgrade
|
| Market Cap Growth | 35.23% | 17.32% | -33.66% | -8.19% | - | - | Upgrade
|
| Enterprise Value | 10,110 | 10,267 | 8,306 | 12,684 | 13,589 | - | Upgrade
|
| Last Close Price | 20.39 | 20.83 | 17.25 | 25.32 | 27.34 | - | Upgrade
|
| PE Ratio | 14.36 | 14.73 | 16.02 | 16.06 | 22.82 | - | Upgrade
|
| Forward PE | 12.17 | 10.92 | 11.33 | - | - | - | Upgrade
|
| PS Ratio | 1.90 | 1.95 | 1.83 | 2.59 | 3.58 | - | Upgrade
|
| PB Ratio | 1.38 | 1.43 | 1.32 | 2.07 | 2.54 | - | Upgrade
|
| P/TBV Ratio | 1.44 | 1.50 | 1.39 | 2.18 | 2.65 | - | Upgrade
|
| P/FCF Ratio | 113.21 | 40.07 | - | 69.15 | - | - | Upgrade
|
| P/OCF Ratio | 26.24 | 16.30 | 18.99 | 14.54 | - | - | Upgrade
|
| EV/Sales Ratio | 1.69 | 1.74 | 1.55 | 2.22 | 3.02 | - | Upgrade
|
| EV/EBITDA Ratio | 7.77 | 8.09 | 8.74 | 10.48 | 13.37 | - | Upgrade
|
| EV/EBIT Ratio | 12.03 | 12.27 | 13.20 | 13.35 | 16.66 | - | Upgrade
|
| EV/FCF Ratio | 100.53 | 35.74 | - | 59.29 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.13 | 0.10 | 0.13 | 0.09 | 0.03 | 0.28 | Upgrade
|
| Debt / EBITDA Ratio | 0.81 | 0.61 | 1.02 | 0.55 | 0.17 | 0.79 | Upgrade
|
| Debt / FCF Ratio | 10.47 | 2.72 | - | 3.11 | - | 3.73 | Upgrade
|
| Asset Turnover | 0.56 | 0.56 | 0.55 | 0.69 | 0.69 | 0.82 | Upgrade
|
| Inventory Turnover | 3.13 | 3.26 | 2.98 | 3.08 | 2.79 | 3.05 | Upgrade
|
| Quick Ratio | 1.57 | 1.52 | 1.45 | 1.93 | 2.40 | 0.92 | Upgrade
|
| Current Ratio | 2.51 | 2.30 | 2.22 | 2.75 | 3.96 | 1.46 | Upgrade
|
| Return on Equity (ROE) | 10.04% | 10.08% | 8.36% | 13.64% | 14.68% | 27.51% | Upgrade
|
| Return on Assets (ROA) | 4.88% | 4.95% | 4.05% | 7.17% | 7.83% | 12.23% | Upgrade
|
| Return on Capital (ROIC) | 5.84% | 6.07% | 4.85% | 8.29% | 9.52% | 16.11% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.70% | 10.20% | 8.00% | 13.20% | 12.80% | 28.40% | Upgrade
|
| Earnings Yield | 7.01% | 6.79% | 6.24% | 6.23% | 4.38% | - | Upgrade
|
| FCF Yield | 0.88% | 2.50% | -2.36% | 1.45% | -3.88% | - | Upgrade
|
| Dividend Yield | 2.94% | 2.88% | 1.75% | 2.37% | 2.56% | - | Upgrade
|
| Payout Ratio | 24.09% | 24.83% | 59.05% | 13.92% | 47.27% | 23.21% | Upgrade
|
| Buyback Yield / Dilution | -1.07% | -0.27% | 0.24% | -9.09% | -8.01% | 0.28% | Upgrade
|
| Total Shareholder Return | 1.89% | 2.61% | 1.99% | -6.72% | -5.45% | 0.28% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.